T1	Person 0 3	Age
T2	Value 4 30	between 18 and 78 year-old
R1	Has_value Arg1:T1 Arg2:T2	
T3	Procedure 42 63	liver transplantation
T4	Temporal 33 41	Previous
R2	Has_temporal Arg1:T3 Arg2:T4	
T5	Temporal 64 81	more than 6 month
R3	Subsumes Arg1:T4 Arg2:T5	
T6	Measurement 85 93	Genotype
T7	Value 94 101	1 and 4
R4	Has_value Arg1:T6 Arg2:T7	
T8	Condition 102 111	infection
R5	AND Arg1:T8 Arg2:T6	
T9	Condition 114 125	Hepatitis C
T10	Multiplier 126 136	recurrence
R6	Has_multiplier Arg1:T9 Arg2:T10	
T11	Measurement 173 192	liver function test
T12	Value 164 172	abnormal
T13	Measurement 203 210	HCV-RNA
T14	Value 194 202	positive
R7	Has_value Arg1:T13 Arg2:T14	
R8	Has_value Arg1:T11 Arg2:T12	
T15	Procedure 212 224	histological
T16	Condition 234 245	hepatitis C
T17	Multiplier 246 256	recurrence
R9	Has_multiplier Arg1:T16 Arg2:T17	
T18	Condition 212 256	histological signs of hepatitis C recurrence
T19	Scope 164 256	abnormal liver function test, positive HCV-RNA, histological signs of hepatitis C recurrence
T20	Scope 114 136	Hepatitis C recurrence
R10	Subsumes Arg1:T20 Arg2:T19	
T21	Measurement 259 269	Viral load
T22	Value 270 281	≥10000UI/mL
R11	Has_value Arg1:T21 Arg2:T22	
T23	Procedure 284 301	Immunosuppression
T24	Drug 307 317	tacrolimus
T25	Drug 325 338	mycophenolate
T26	Drug 340 350	Prednisone
T27	Multiplier 369 377	low dose
T28	Value 379 387	≤10 mg/d
R14	Subsumes Arg1:T27 Arg2:T28	
R15	Has_multiplier Arg1:T26 Arg2:T27	
T29	Scope 307 388	tacrolimus and/or mycophenolate (Prednisone use is allowed at low dose, ≤10 mg/d)
R12	Has_scope Arg1:T23 Arg2:T29	
*	OR T24 T25 T26
T30	Condition 391 406	Treatment naïve
T31	Condition 410 431	treatment experienced
*	OR T30 T31
T32	Procedure 433 440	Peg-RBV
T33	Procedure 444 458	triple therapy
*	OR T32 T33
T34	Scope 433 458	Peg-RBV or triple therapy
T35	Scope 391 431	Treatment naïve or treatment experienced
R13	Has_scope Arg1:T35 Arg2:T34	
